Many results have shown that IL-33 may have an unknown role in diabetes and cardiac complications of obesity because the precise effect of IL-33 in the progress of many metabolic diseases, including diabetes, seems to be unpredictable [44]. This evidence concerns the gene IL33 and metabolic disease.